Cytarabine dose of 36 g/m² compared with 12 g/m² within first consolidation in acute myeloid leukemia: results of patients enrolled onto the prospective randomized AML96 study.
作者:
主题词
青少年(Adolescent);成年人(Adult);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);阿糖胞苷(Cytarabine);细胞遗传学(Cytogenetics);无病生存(Disease-Free Survival);女(雌)性(Female);人类(Humans);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);男(雄)性(Male);中年人(Middle Aged);米托蒽醌(Mitoxantrone);比例危险度模型(Proportional Hazards Models);前瞻性研究(Prospective Studies);缓解诱导(Remission Induction);危险(Risk);治疗结果(Treatment Outcome)
DOI
10.1200/JCO.2010.33.7303
PMID
21606413
发布时间
2022-03-31
- 浏览40

Journal of clinical oncology
2696-702页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文